Table 1 Baseline characteristics of NOMED-AF and Polish population

Age overall

77.5 ± 8.06

74.5 ± 7.59

77.6 ± 7.54

75.1 ± 7.2

 65–69 years

430 [20]

35 (32.8–36.9)

142 [16]

27 (23.6–30.9)

 70–74 years

435 [20]

22 (20.3–23.9)

197 [22]

26 (23.1–29.1)

 75–79 years

396 [19]

16 (15.1–17.5)

189 [21]

20 (17.4–22.1)

 80–84 years

361 [17]

13 (12.1–14.7)

168 [19]

15 (13.1–17.7)

 85–89 years

324 [15]

9 (8.3–9.7)

118 [13]

8 (6.6–10)

 ≥ 90 years

187 [9]

5 (4.2–5)

67 [8]

4 (3.2–4.7)

Female

1070 [50]

62 (60.3-63.9)

409 [46]

57 (53.5–60.4)

BMI (kg/m²)

27.33 ± 4.560

27.50 ± 4.625

29.77 ± 4.949

30.35 ± 4.981

Hypertension

1623 [77]

76 (74–77.8)

810 [92]

93 (91.8–94.7)

Heart failure

431 [20]

16 (14.2–17.2)

242 [28]

25 (22.5–28.3)

Chronic kidney disease (eGFR < 60ml/min)

524 [29]

24 (21.8–25.4)

285 [37]

32 (29.2–35.9)

Chronic kidney disease (TOTAL)

641 [31]

24 (22.6–26)

364 [42]

37 (33.5–39.9)

Haemodialysis

3[2]

1 (0.4–2.8)

5 [5]

3 (1–7.4)

Stroke

165 [8]

7 (5.–7.8)

118 [13]

13 (10.8–15)

Ischemic cerebral stroke

124 [6]

5 (4.1–5.8)

82 [9]

9 (7.1–10.3)

Intracranial haemorrhage

12 [1]

1 (0.3-1)

4 [0.5]

1 (0.2-2)

Unclassified stroke

29 [1]

1 (1-1.8)

32 [4]

3 (2.4-4.9)

TIA

121 [6]

5 (3.8-5.4)

65 [7]

7 (5.4-9.2)

Coronary heart disease

392 [19]

16 (14.9–18.3)

274 [31]

29 (26.5–32.6)

Myocardial infarction

253 [12]

10 (9.2–11.7)

193 [22]

21 (18.7–24.3)

Peripheral artery disease

268 [13]

11 (9.5–11.9)

147 [17]

15 (12.7–17.1)

CHA₂DS₂VASc (points)

3.60 ± 1.416

3.44 ± 1.384

5.08 ± 1.400

4.97 ± 1.414

CHA₂DS₂VASc in AF patients

4.12 ± 1.542

3.97 ± 1.591

5.49 ± 1.372

5.47 ± 1.444

CHA₂DS₂VASc in SAF patients

3.87 ± 1.543

3.74 ± 1.591

5.56 ± 1.450

5.57 ± 1.531